CTD401 / Nanjing Bioheng Biotech  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
CTD401 / Nanjing Bioheng Biotech
NCT04620655: RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL

Recruiting
N/A
24
RoW
RD13-01 cell infusion
Min Xiang
T Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma
11/21
11/22

Download Options